AKT1 and ovarian carcinoma: High levels of miR-29a-3p expression inhibit PD-L1 expression in ovarian cancer cells by downregulating the FOXO3-AKT/GSK3β axis, leading to immune escape of OC cells and ultimately promoting the proliferation of ovarian cancer cells (252).